Kerstin Noelle Vokinger
13PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Apr 01, 2026
Review Duration and Therapeutic Value of Cancer Drugs Granted Priority Versus Nonpriority Review in the United States, European Union, and Switzerland (2010-2024).Simon Hediger, Lara Welti, Camille E G Glaus
|Feb 02, 2026
Quantification of Age and Sex Ratio Differences between Trial and Target Population for New Drugs.Miquel Serra-Burriel, Paul Schlossmacher, Kerstin Noelle Vokinger
|Oct 06, 2025
Therapeutic benefit of the most expensive drugs covered by Medicare and Medicaid.Tiffany Enxia Jiang, Reshma Ramachandran, Kerstin N Vokinger
|Sep 26, 2025
Generic competition and price developments in the USA, Germany and Switzerland (2007-2023): a longitudinal observational study.Simon Hediger, Luca Locher, Kerstin Noëlle Vokinger
|Jul 07, 2025
Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023) : A Cross-Sectional Study.Kerstin N Vokinger, Miquel Serra-Burriel, Camille E G Glaus
Pageof 3
Frequent Collaborators
4 joint publications
Aaron S Kesselheim
3 joint publications
Miquel Serra-Burriel
2 joint publications
Ariadna Tibau
2 joint publications
Ulrich-Peter Rohr
2 joint publications
Joseph S Ross
1 joint publications
Melissa Newham
1 joint publications
Thomas J Hwang
1 joint publications
Simon Dalla Torre di Sanguinetto
1 joint publications
Tiffany Enxia Jiang
1 joint publications
Reshma Ramachandran